Patents-Review.com
🔗 Permalink
Assignee profile:

NEOVACS

City:

Paris

Country:

France

Published Applications:

20

Last publication date:

2025-10-09

Patent Grants:

15

Last grant date:

2024-08-13

Top Inventors for applications by NEOVACS

These are the the leading inventors for applications assigned to NEOVACS:

Recent patent applications by NEOVACS

NEOVACS based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-10-09
US20250312427A1
Human necessities

mRNA VACCINES COMPRISING IL-4 AND/OR IL-13 RNA AND USES THEREOF

 #2 | 2025-01-23
US20250025541A1
Human necessities

IMMUNOGENIC PRODUCT COMPRISING IL-4 AND/OR IL-13 FOR TREATING DISORDERS ASSOCIATED WITH ABERRANT IL-4 AND/OR IL 13 EXPRESSION OR ACTIVITY

 #3 | 2023-11-16
US20230364232A1
Human necessities

IMMUNOGENIC PRODUCT COMPRISING AN IgE FRAGMENT FOR TREATING IgE-MEDIATED INFLAMMATORY DISORDERS

 #4 | 2021-07-08 ✅ Patent 12,059,457 granted on 2024-08-13
US20210205427A1
Human necessities

Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity

 #5 | 2014-01-23 ✅ Patent 9,993,565 granted on 2018-06-12
US20140023617A1
Human necessities

Method for treating IFNalpha related conditions

 #6 | 2012-06-14
US20120148526A1
Chemistry; metallurgy

STRONGLY INACTIVATED AND STILL HIGHLY IMMUNOGENIC VACCINE AND PROCESS OF MANUFACTURING THEREOF

 #7 | 2011-10-13 ✅ Patent 8,697,047 granted on 2014-04-15
US20110250174A1
Human necessities

Stable immunogenic product comprising antigenic heterocomplexes

 #8 | 2008-08-14 ✅ Patent 7,887,811 granted on 2011-02-15
US20080193473A1
Human necessities

Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein

 #9 | 2008-02-07 ✅ Patent 8,101,165 granted on 2012-01-24
US20080031849A1
Human necessities

Use of immunogens to treat or prevent, in malignant tumors, the immune or vascular disorders induced by extracellular factors

 #10 | 2007-08-30 ✅ Patent 8,679,483 granted on 2014-03-25
US20070202102A1
Chemistry; metallurgy

High-yield method for the production of human antibodies blocking the biological activity of a human cytokine

 #11 | 2006-11-09
US20060252075A1
Physics

Method for monitoring anti-HIV treatment in HIV infected individuals

 #12 | 2006-10-19 ✅ Patent 7,314,629 granted on 2008-01-01
US20060233820A1
Chemistry; metallurgy

Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus

 #13 | 2006-07-13 ✅ Patent 7,351,554 granted on 2008-04-01
US20060153863A1
Chemistry; metallurgy

Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's

 #14 | 2006-07-13 ✅ Patent 7,504,479 granted on 2009-03-17
US20060153862A1
Chemistry; metallurgy

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

 #15 | 2006-04-04 ✅ Patent 7,022,482 granted on 2006-04-04
US10465645
-

Use of immunogenic immunosuppressive and/or angiogenic proteins which have been rendered inactive, process for their preparation and pharmaceutical or vaccinal uses

 #16 | 2006-03-30 ✅ Patent 7,972,603 granted on 2011-07-05
US20060067944A1
Human necessities

Stable immunogenic product comprising antigenic heterocomplexes

 #17 | 2006-03-21 ✅ Patent 7,015,016 granted on 2006-03-21
US10168115
-

Use of inactivated immunosuppressive or angiogenic immunogenic proteins for producing secretory IgA's

 #18 | 2006-01-19 ✅ Patent 8,372,388 granted on 2013-02-12
US20060013800A1
Human necessities

Method for preparing a stable TNF-α vaccine

 #19 | 2005-08-18 ✅ Patent 7,208,148 granted on 2007-04-24
US20050180950A1
Chemistry; metallurgy

Chemically modified cytokines

 #20 | 2005-04-12 ✅ Patent 6,878,370 granted on 2005-04-12
US9959461
-

Chemically modified TNF-α

Also check out NEOVACS's (Paris, France) applicant profile with 3 patent applications submitted.

AssigneeID:

52591 ⎘